SearcharxivSearch

arXiv subjects

Donald Berry

Publications and source records attributed to Donald Berry.

2 recordsLinked to original sources

Time-Resolved EEG Decoding of Semantic Processing Reveals Altered Neural Dynamics in Depression and Suicidality

Depression and suicidality affect cognitive and emotional processes, yet objective, task-evoked neural readouts of mental health remain limited. We investigated the spatiotemporal dynamics of affective semantic processing using multivariate decoding of time-resolved, 64-channel electroencephalography (EEG). Participants (N=137) performed a sentence-evaluation task with emotionally salient, self-referential statements. We identified robust neural signatures of semantic processing, with peak decoding accuracy between 300-600 ms -- a window associated with rapid, stimulus-driven semantic evaluation and conflict monitoring. Relative to healthy controls, individuals with depression and suicidal ideation showed earlier onset, longer duration, and greater amplitude decoding responses, along with broader cross-temporal generalization and enhanced contributions from frontocentral and parietotemporal components. These findings suggest altered sensitivity and impaired disengagement from emotionally salient content in the clinical groups, advancing our understanding of the neurocognitive basis of mental health and establishing a compact and interpretable EEG-based index of semantic-evaluation dynamics with potential diagnostic relevance.

q-bio.NC

A Nonparametric Bayesian Basket Trial Design

Targeted therapies on the basis of genomic aberrations analysis of the tumor have shown promising results in cancer prognosis and treatment. Regardless of tumor type, trials that match patients to targeted therapies for their particular genomic aberrations have become a mainstream direction of therapeutic management of patients with cancer. Therefore, finding the subpopulation of patients who can most benefit from an aberration-specific targeted therapy across multiple cancer types is important. We propose an adaptive Bayesian clinical trial design for patient allocation and subpopulation identification. We start with a decision theoretic approach, including a utility function and a probability model across all possible subpopulation models. The main features of the proposed design and population finding methods are that we allow for variable sets of covariates to be recorded by different patients, adjust for missing data, allow high order interactions of covariates, and the adaptive allocation of each patient to treatment arms using the posterior predictive probability of which arm is best for each patient. The new method is demonstrated via extensive simulation studies.

stat.AP